Publications by authors named "Timothy Pasquale"

Claim this Profile
N
Novel developments in the treatment of acute bacterial skin and skin structure infections.
Rupal K Jaffa, Kelly E Pillinger, Danya Roshdy, Jacqueline A Isip, Timothy R Pasquale

Expert Opin Pharmacother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal use in immunocompetent, critically ill patients with pneumonia does not improve clinical outcomes.
Meagan Griffin, Desiree E Kosmisky, Megan A Templin, Toan Huynh, Lewis H McCurdy, Timothy R Pasquale

Heart Lung· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating a Pharmacist Into the Discharge Process: A Unit-Based Transitions of Care Pilot.
Hanlin Li, William Guffey, Laura Honeycutt, Timothy Pasquale, Nigel L Rozario

Hosp Pharm· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.
Timothy R Pasquale, Michael J Tan, Tamara L Trienski, Thomas M File

J Chemother· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency.
Christy Maggiore, Timothy Pasquale, Phillip Cole, H David Friedland

Expert Rev Clin Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections.
Timothy R Pasquale, Tamara L Trienski, Deanna E Olexia, Joseph P Myers, Michael J Tan

Am J Health Syst Pharm· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit.
Bryan M Bishop, John J Bon, Tamara L Trienski, Timothy R Pasquale, Bradley R Martin

Ann Pharmacother· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and use of a rapid Staphylococcus aureus assay by an antimicrobial stewardship program.
Tamara L Trienski, Heather L Barrett, Timothy R Pasquale, Joseph R DiPersio, Thomas M File

Am J Health Syst Pharm· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.
Timothy R Pasquale, Bonnie Jabrocki, Sara-Jane Salstrom, Timothy L Wiemken, Paula Peyrani

Int J Infect Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maraviroc: a coreceptor CCR5 antagonist for management of HIV infection.
Raymond Yost, Timothy R Pasquale, Eric G Sahloff

Am J Health Syst Pharm· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on antimicrobial agents: new indications of older agents.
Timothy R Pasquale, James S Tan

Expert Opin Pharmacother· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonantimicrobial effects of antibacterial agents.
Timothy R Pasquale, James S Tan

Clin Infect Dis· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis